The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•8 April 2026•

1 min read

José Almeida Appointed CEO of Hologic Following Private Equity Buyout

Portrait of Elon Musk over a golden world map showing Tesla cars, factories, and a red downward trend line.

Key Facts

1José Almeida, former CEO of Baxter International and Covidien, has been named the new CEO of Hologic Inc.

2Hologic transitioned to private ownership following a buyout by two private equity firms.

3Nine board members resigned as the company transitioned to private ownership.

Hologic Inc., a prominent medical device manufacturer, has appointed industry veteran José Almeida as its new Chief Executive Officer. Almeida brings a wealth of experience to the role, having previously led major healthcare firms including Baxter International and Covidien. This leadership transition follows Hologic's recent move to private ownership after a successful buyout by two private equity firms. In conjunction with the restructuring, nine members of the company’s board of directors have resigned. The appointment of a high-profile executive like Almeida is viewed as a strategic move to navigate the company's next phase under private equity control. While the news marks a significant corporate development, its direct impact on public equity markets is limited due to the company's delisting from public exchanges.